First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

JIAN-RI LI; SHIAN-SHIANG WANG; KEVIN LU; CHAUN-SHU CHEN; CHEN-LI CHENG; SHENG-CHUN HUNG; KUN-YUAN CHIU; CHIANN YI HSU; CHENG-KUANG YANG

doi:10.21873/anticanres.16281

Research ArticleClinical Studies

First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

JIAN-RI LI, SHIAN-SHIANG WANG, KEVIN LU, CHAUN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU and CHENG-KUANG YANG

Anticancer Research March 2023, 43 (3) 1331-1339; DOI: https://doi.org/10.21873/anticanres.16281

JIAN-RI LI

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

2Division of Surgical Intensive Care Unit, Department of Intensive Care, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

3Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.;

4Department of Medicine and Nursing, Hungkuang University, Taichung, Taiwan, R.O.C.;

5Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHIAN-SHIANG WANG

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

3Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.;

6Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KEVIN LU

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHAUN-SHU CHEN

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

3Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHEN-LI CHENG

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

3Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHENG-CHUN HUNG

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

3Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KUN-YUAN CHIU

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

6Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHIANN YI HSU

7Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

CHENG-KUANG YANG

1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gu5121@vghtc.gov.tw

Article
Figures & Data
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 43, Issue 3

March 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 9 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

JIAN-RI LI, SHIAN-SHIANG WANG, KEVIN LU, CHAUN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU, CHENG-KUANG YANG

Anticancer Research Mar 2023, 43 (3) 1331-1339; DOI: 10.21873/anticanres.16281

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

JIAN-RI LI, SHIAN-SHIANG WANG, KEVIN LU, CHAUN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU, CHENG-KUANG YANG

Anticancer Research Mar 2023, 43 (3) 1331-1339; DOI: 10.21873/anticanres.16281

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

Immune check point inhibitors
Urothelial carcinoma
cisplatin
pembrolizumab
Atezolizumab

Main menu

User menu

Search

First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords